Caitong International Asset Management’s Clover Health Investments CLOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$202K Buy
38,464
+28,645
+292% +$97.3K 0.03% 426
2026
Q1
$17.3K Buy
+9,819
New +$21.3K ﹤0.01% 1011
2025
Q4
– Sell
-1,953
Closed -$5.98K – 1951
2025
Q3
$5.98K Buy
1,953
+781
+67% +$2.23K ﹤0.01% 1180
2025
Q2
$3.27K Buy
+1,172
New +$3.85K ﹤0.01% 1201
2025
Q1
– Sell
-13,306
Closed -$41.9K – 2213
2024
Q4
$41.9K Buy
+13,306
New +$47.6K 0.04% 540

Other funds holding CLOV

Caitong International Asset Management's CLOV Position: Q2 2026 in Review

Caitong International Asset Management increased its Clover Health Investments (CLOV) stake by 292% in Q2 2026, buying an estimated $97.3K and bringing the position to 38,464 shares worth $202K. The position accounts for 0.03% of the portfolio, ranked #426.

Caitong International Asset Management first reported a position in CLOV in Q4 2024 and has held it in 5 quarters since. 227 funds tracked by Wall St. Rank hold CLOV as of Q2 2026.

  • Caitong International Asset Management held 38,464 shares of Clover Health Investments worth $202K as of Q2 2026.
  • Caitong International Asset Management bought 28,645 Clover Health Investments shares in Q2 2026, an estimated $97.3K.
  • Clover Health Investments made up 0.03% of Caitong International Asset Management's portfolio in Q2 2026, its #426 holding.
  • Caitong International Asset Management first reported a position in Clover Health Investments in Q4 2024 and has held it in 5 quarters since.
  • 227 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.